Internal Documents: Purdue Pharma Knew OxyContin’s Risks, Pushed It Anyway
EPIDEMIC
Marketing records made public for the first time show the opioid maker was repeatedly warned about addiction and fatalities—but focused on telling doctors how to profit from it.
